Literature DB >> 33691477

Smooth Muscle Cell-Specific PKM2 (Pyruvate Kinase Muscle 2) Promotes Smooth Muscle Cell Phenotypic Switching and Neointimal Hyperplasia.

Manish Jain1, Nirav Dhanesha1, Prakash Doddapattar1, Manasa K Nayak1, Liang Guo2, Anne Cornelissen2, Steven R Lentz1, Aloke V Finn2, Anil K Chauhan1.   

Abstract

[Figure: see text].

Entities:  

Keywords:  glycolysis; hyperplasia; neointima; phenotype; pyruvate kinase muscle 2

Mesh：

Substances：

Year:  2021        PMID： 33691477      PMCID： PMC8062279          DOI： 10.1161/ATVBAHA.121.316021

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN： 1079-5642            Impact factor:   8.311


  36 in total

1.  Pyruvate kinase M2 activation protects against the proliferation and migration of pulmonary artery smooth muscle cells.

Authors:  Aikai Zhang; Fenfang Yu; Wande Yu; Peng Ye; Pengfei Liu; Yue Gu; Shaoliang Chen; Hang Zhang
Journal:  Cell Tissue Res       Date:  2020-07-27       Impact factor: 5.249

2.  Involvement of interleukin-1 receptor-associated kinase-1 in vascular smooth muscle cell proliferation and neointimal formation after rat carotid injury.

Authors:  Manish Jain; Ankita Singh; Vishal Singh; Manoj Kumar Barthwal
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-04-23       Impact factor: 8.311

3.  STAT3 Protein Regulates Vascular Smooth Muscle Cell Phenotypic Switch by Interaction with Myocardin.

Authors:  Xing-Hua Liao; Nan Wang; Dong-Wei Zhao; De-Liang Zheng; Li Zheng; Wen-Jing Xing; Wen-Jian Ma; Le-Yuan Bao; Jian Dong; Tong-Cun Zhang
Journal:  J Biol Chem       Date:  2015-06-22       Impact factor: 5.157

4.  Cooperation and competition in the evolution of ATP-producing pathways.

Authors:  T Pfeiffer; S Schuster; S Bonhoeffer
Journal:  Science       Date:  2001-03-29       Impact factor: 47.728

5.  Pyruvate kinase type M2 contributes to the development of pancreatic ductal adenocarcinoma by regulating the production of metabolites and reactive oxygen species.

Authors:  Misa Yokoyama; Nobuhiro Tanuma; Rie Shibuya; Takeharu Shiroki; Makoto Abue; Kuniharu Yamamoto; Koh Miura; Kazunori Yamaguchi; Ikuro Sato; Keiichi Tamai; Kennichi Satoh
Journal:  Int J Oncol       Date:  2018-01-30       Impact factor: 5.650

Review 6.  Dual roles of PKM2 in cancer metabolism.

Authors:  Songfang Wu; Huangying Le
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2012-12-04       Impact factor: 3.848

7.  PKM2-dependent glycolysis promotes the proliferation and migration of vascular smooth muscle cells during atherosclerosis.

Authors:  Xuezhu Zhao; Fancheng Tan; Xiaoru Cao; Zhengyu Cao; Bicheng Li; Zhaoqian Shen; Ye Tian
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2020-01-02       Impact factor: 3.848

8.  Nuclear PKM2 regulates β-catenin transactivation upon EGFR activation.

Authors:  Weiwei Yang; Yan Xia; Haitao Ji; Yanhua Zheng; Ji Liang; Wenhua Huang; Xiang Gao; Kenneth Aldape; Zhimin Lu
Journal:  Nature       Date:  2011-12-01       Impact factor: 49.962

9.  Pkm2 can enhance pluripotency in ESCs and promote somatic cell reprogramming to iPSCs.

Authors:  Shengtang Qin; Danli Yang; Kang Chen; Haolan Li; Liqiang Zhang; Yuan Li; Rongrong Le; Xiaojie Li; Shaorong Gao; Lan Kang
Journal:  Oncotarget       Date:  2017-09-06

10.  ERK1/2-dependent phosphorylation and nuclear translocation of PKM2 promotes the Warburg effect.

Authors:  Weiwei Yang; Yanhua Zheng; Yan Xia; Haitao Ji; Xiaomin Chen; Fang Guo; Costas A Lyssiotis; Kenneth Aldape; Lewis C Cantley; Zhimin Lu
Journal:  Nat Cell Biol       Date:  2012-11-25       Impact factor: 28.824
View more
  7 in total

Review 1.  Role of Pyruvate Kinase M2 (PKM2) in Cardiovascular Diseases.

Authors:  Mohd Rihan; Shyam Sunder Sharma
Journal:  J Cardiovasc Transl Res       Date:  2022-09-30       Impact factor: 3.216

2.  Glucose consumption of vascular cell types in culture: toward optimization of experimental conditions.

Authors:  Keiichi Torimoto; Keisuke Okuno; Ryohei Kuroda; No'Ad Shanas; Stephanie M Cicalese; Kunie Eguchi; Katherine J Elliott; Tatsuo Kawai; Cali B Corbett; Amanda M Peluzzo; Amanda K St Paul; Michael V Autieri; Rosario Scalia; Victor Rizzo; Tomoki Hashimoto; Satoru Eguchi
Journal:  Am J Physiol Cell Physiol       Date:  2021-11-24       Impact factor: 5.282

3.  Myeloid Cell PKM2 Deletion Enhances Efferocytosis and Reduces Atherosclerosis.

Authors:  Prakash Doddapattar; Rishabh Dev; Madankumar Ghatge; Rakesh B Patel; Manish Jain; Nirav Dhanesha; Steven R Lentz; Anil K Chauhan
Journal:  Circ Res       Date:  2022-04-11       Impact factor: 23.213

4.  Cathepsin B-Cleavable Polymeric Photosensitizer Prodrug for Selective Photodynamic Therapy: In Vitro Studies.

Authors:  Manish Jain; Jordan Bouilloux; Ines Borrego; Stéphane Cook; Hubert van den Bergh; Norbert Lange; Georges Wagnieres; Marie-Noelle Giraud
Journal:  Pharmaceuticals (Basel)       Date:  2022-04-30

5.  PKM2 promotes neutrophil activation and cerebral thromboinflammation: therapeutic implications for ischemic stroke.

Authors:  Nirav Dhanesha; Rakesh B Patel; Prakash Doddapattar; Madankumar Ghatge; Gagan D Flora; Manish Jain; Daniel Thedens; Heena Olalde; Mariia Kumskova; Enrique C Leira; Anil K Chauhan
Journal:  Blood       Date:  2022-02-24       Impact factor: 25.476

Review 6.  Role of Integrins in Modulating Smooth Muscle Cell Plasticity and Vascular Remodeling: From Expression to Therapeutic Implications.

Authors:  Manish Jain; Anil K Chauhan
Journal:  Cells       Date:  2022-02-13       Impact factor: 6.600

Review 7.  Recent advance in treatment of atherosclerosis: Key targets and plaque-positioned delivery strategies.

Authors:  Li Li; Sainan Liu; Jianying Tan; Lai Wei; Dimeng Wu; Shuai Gao; Yajun Weng; Junying Chen
Journal:  J Tissue Eng       Date:  2022-03-24       Impact factor: 7.813
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.